Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Oncology|October 31, 2003
Antiblastic drug combinations with ifosfamide: an updateF Fulfaro, M R Valerio, G Badalamenti, et al.Journal of Chemotherapy (Florence, Italy)|November 30, 2006
A case of Guillain-Barré syndrome in a patient with non small cell lung cancer treated with chemotherapyG Cicero, F Fulfaro, A Caraceni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
The role of Aurora-A inhibitors in cancer therapyV Agnese, V Bazan, F P Fiorentino, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Founder mutations in BRCA1 and BRCA2 genesR Ferla, V Calò, S Cascio, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosisG Campisi, O Di Fede, A Musciotto, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinomaM R Valerio, P Tagliaferri, F Raspagliesi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancersF Verderame, A Russo, R Di Leo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular featuresG Badalamenti, V Rodolico, F Fulfaro, et al.Journal of Chemotherapy (Florence, Italy)|December 6, 2005
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkersF Fulfaro, G Leto, G Badalamenti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily)A Russo, V Calò, C Augello, et al.Pageof 3